Lux
Portfolio in Israel · United States: 3 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback3startups, 2 countries
In a ranking2ranked by AI-estimated valuation
On the Radar1eligible, not ranked
Latest deal trackedSep 2026Covenant
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Kela | #29 Israel | Defence tech › battlefield operating system | Series B · USD 200M · May 2026 | Unicorn |
| Xaira Therapeutics | #3 AI drug discovery | Healthtech › Biotech › AI drug discovery | Launch financing · USD 1B+ committed · Apr 2024 | Unicorn |
| Covenant | Radar | Defence tech › long-range precision strike | Three rounds · USD 250M+ · Sep 2026 | Not estimated |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12024
02025
22026
Co-investors
Sequoia Capital ×2 · Stripes · D1 Capital Partners · Andreessen Horowitz · Founders Fund · ARCH Venture Partners · Foresite Labs · F-Prime · NEA · Lightspeed
Investors that joined the same rounds, as reported by public sources.
Sources. biospace.com, bloomberg.com, fiercebiotech.com, jpost.com, as cited on each company’s profile.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.